Showing results (1651-1660 of 2,368) with videos related to
Sort By:
Pageof 237
Pediatrics|December 28, 2016
Racial Disparities in Medicaid Asthma HospitalizationsJeffrey H Silber, Paul R Rosenbaum, Shawna R Calhoun, et al.Neuro-Oncology Advances|October 21, 2024
A phase II, open-label, single-arm trial of pembrolizumab for recurrent meningioma and solitary fibrous tumorDror Limon, Alexandra Amiel, Shaked Even Haim, et al.Stem Cell Research & Therapy|February 6, 2024
Osteogenic human MSC-derived extracellular vesicles regulate MSC activity and osteogenic differentiation and promote bone regeneration in a rat calvarial defect modelNiyaz Al-Sharabi, Samih Mohamed-Ahmed, Siddharth Shanbhag, et al.BMC Surgery|August 1, 2023
Impact of para aortic lymph node removal on survival following resection for pancreatic adenocarcinomaMartin Sillesen, Carsten Palnæs Hansen, Stefan Kobbelgaard Burgdorf, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 1, 2023
Prognostic significance of delayed complete metabolic response on PET/CT after primary chemoradiation treatment of cervical cancerNadav Michaan, Atalia Wenkert, Einat Even-Sapir, et al.Frontiers in Cell and Developmental Biology|January 9, 2023
Bortezomib abrogates temozolomide-induced autophagic flux through an ATG5 dependent pathwayMohummad Aminur Rahman, Agnete S T Engelsen, Shahin Sarowar, et al.Advanced Materials (Deerfield Beach, Fla.)|December 20, 2022
Many-Body Correlations and Exciton Complexes in CsPbBr3 Quantum DotsChenglian Zhu, Tan Nguyen, Simon C Boehme, et al.Journal of Orthopaedic Trauma|March 21, 2012
Preoperative skeletal versus cutaneous traction for femoral shaft fractures treated within 24 hoursJesse L Even, Justin E Richards, Colin G Crosby, et al.ACS Nano|April 14, 2012
Three-dimensional self-assembling of gold nanorods with controlled macroscopic shape and local smectic B orderCyrille Hamon, Marie Postic, Elsa Mazari, et al.Bulletin Du Cancer|November 19, 2009
[New drugs and targeted therapeutic agents in ovarian cancer]T de La Motte Rouge, M-C Petrella, J Michels, et al.Pageof 237